Beacon
Jake Bird has extensive experience in product development research operations, having worked at Beacon Targeted Therapies since September 2020. Prior to this, at Priory Group from November 2017 to September 2020, Jake held the title of Healthcare Assistant/Safeguarding Lead. Jake's academic background includes education at UCL and the University of Sydney.
Beacon
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape. With Beacon, you can make drug development decisions with confidence. This is why 23 out of the world’s top 25 drug developers trust us.